Brief: Bellus Health Inc - Bellus To Own 100% Of BLU-5937 And Related P2X3 Antagonists Intellectual Property With No Future Payments Due
23/03/2020 11:53
March 23 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH INC - BELLUS TO OWN 100% OF BLU-5937 AND
RELATED
P2X3 ANTAGONISTS INTELLECTUAL PROPERTY WITH NO FUTURE PAYMENTS
DUE
* BELLUS HEALTH INC - 4.77 MILLION BELLUS HEALTH COMMON
SHARES TO
BE ISSUED IN CONSIDERATION FOR DEAL
Source text for Eikon: ID:nBw3m6VKga
Further company coverage: BLU.TO
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln